These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 26358181)

  • 1. Breast cancer and immunology: biomarker and therapeutic developments.
    Santa-Maria CA; Park SJ; Jain S; Gradishar WJ
    Expert Rev Anticancer Ther; 2015; 15(10):1215-22. PubMed ID: 26358181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumour-infiltrating lymphocytes and the emerging role of immunotherapy in breast cancer.
    Luen SJ; Savas P; Fox SB; Salgado R; Loi S
    Pathology; 2017 Feb; 49(2):141-155. PubMed ID: 28049579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New Immunotherapy Strategies in Breast Cancer.
    Yu LY; Tang J; Zhang CM; Zeng WJ; Yan H; Li MP; Chen XP
    Int J Environ Res Public Health; 2017 Jan; 14(1):. PubMed ID: 28085094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunology and breast cancer: toward a new way of understanding breast cancer and developing novel therapeutic strategies.
    Gingras I; Azim HA; Ignatiadis M; Sotiriou C
    Clin Adv Hematol Oncol; 2015 Jun; 13(6):372-82. PubMed ID: 26352893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Checkpoint inhibitors in advanced melanoma: effect on the field of immunotherapy.
    O'reilly A; Larkin J
    Expert Rev Anticancer Ther; 2017 Jul; 17(7):647-655. PubMed ID: 28604130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles of cancer/testis antigens (CTAs) in breast cancer.
    Li Y; Li J; Wang Y; Zhang Y; Chu J; Sun C; Fu Z; Huang Y; Zhang H; Yuan H; Yin Y
    Cancer Lett; 2017 Jul; 399():64-73. PubMed ID: 28274891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapy for breast cancer: past, present, and future.
    Spellman A; Tang SC
    Cancer Metastasis Rev; 2016 Dec; 35(4):525-546. PubMed ID: 27913998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of inflammation in progression of breast cancer: Friend or foe? (Review).
    Allen MD; Jones LJ
    Int J Oncol; 2015 Sep; 47(3):797-805. PubMed ID: 26165857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic and predictive immune gene signatures in breast cancer.
    Bedognetti D; Hendrickx W; Marincola FM; Miller LD
    Curr Opin Oncol; 2015 Nov; 27(6):433-44. PubMed ID: 26418235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multimodal approaches to improve immunotherapy in breast cancer.
    Basu A; Kodumudi K
    Immunotherapy; 2020 Feb; 12(3):161-165. PubMed ID: 32157934
    [No Abstract]   [Full Text] [Related]  

  • 11. Development of Tumor Markers for Breast Cancer Immunotherapy.
    Fang Q; Shen G; Xie Q; Guan Y; Liu X; Ren D; Zhao F; Liu Z; Ma F; Zhao J
    Curr Mol Med; 2024; 24(5):547-564. PubMed ID: 37157196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune Checkpoint inhibitors: An introduction to the next-generation cancer immunotherapy.
    Lee L; Gupta M; Sahasranaman S
    J Clin Pharmacol; 2016 Feb; 56(2):157-69. PubMed ID: 26183909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast Cancer Immunology and Immunotherapy: Current Status and Future Perspectives.
    de la Cruz-Merino L; Chiesa M; Caballero R; Rojo F; Palazón N; Carrasco FH; Sánchez-Margalet V
    Int Rev Cell Mol Biol; 2017; 331():1-53. PubMed ID: 28325210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MUC1-based recombinant Bacillus Calmette-Guerin vaccines as candidates for breast cancer immunotherapy.
    Yuan S; Shi C; Liu L; Han W
    Expert Opin Biol Ther; 2010 Jul; 10(7):1037-48. PubMed ID: 20420512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in breast cancer immunotherapy: The promising impact of nanomedicines.
    Hashemzadeh N; Dolatkhah M; Adibkia K; Aghanejad A; Barzegar-Jalali M; Omidi Y; Barar J
    Life Sci; 2021 Apr; 271():119110. PubMed ID: 33513401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toward a breast cancer vaccine: work in progress.
    Emens LA; Jaffee EM
    Oncology (Williston Park); 2003 Sep; 17(9):1200-11; discussion 1214, 1217-8. PubMed ID: 14569849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What is the role of immunotherapy in breast cancer?
    Tan TJ; Chan JJ; Kamis S; Dent RA
    Chin Clin Oncol; 2018 Apr; 7(2):13. PubMed ID: 29764158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging drugs targeting PD-1 and PD-L1: reality or hope?
    Casaluce F; Sgambato A; Sacco PC; Palazzolo G; Maione P; Rossi A; Ciardiello F; Gridelli C
    Expert Opin Emerg Drugs; 2014 Dec; 19(4):557-69. PubMed ID: 25253438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast cancer genomics and immuno-oncological markers to guide immune therapies.
    Hammerl D; Smid M; Timmermans AM; Sleijfer S; Martens JWM; Debets R
    Semin Cancer Biol; 2018 Oct; 52(Pt 2):178-188. PubMed ID: 29104025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunotherapy of breast cancer.
    Wright SE
    Expert Opin Biol Ther; 2012 Apr; 12(4):479-90. PubMed ID: 22413825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.